Neural stem cell induction differentiation medium and neural stem cell induction differentiation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING CELLAPY BIOTECH
- Publication Date
- 2019-02-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedicine, in particular to a neural stem cell induction differentiation medium and a neural stem cell induction differentiation method. Background technique
[0002] In 2006 and 2007, Japanese scholar Shinya Yamanaka successfully introduced four transcription factors (Oct4, Sox2, Klf4 and c-Myc) into mice respectively (Takahashi and Yamanaka., 2006). and human (Takahashi et al., 2007) skin fibroblasts were reprogrammed into induced pluripotent stem cells (Induced Pluripotent Stem Cells, iPSCs), and thus won the 2012 Nobel Prize in Medicine and Physiology. hiPS cells (human induced pluripotent stem cells) have all the differentiation capabilities of hES cells (human embryonic stem cells) and have no ethical issues. They will completely replace hES cells in the near future and become the most important cell source for regenerative medicine.
[0003] Neuroscience research includes the whole process of it...